<DOC>
	<DOC>NCT00147719</DOC>
	<brief_summary>The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.</brief_summary>
	<brief_title>WelCholÂ® With Metformin in Treating Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Age 1875 years, inclusive Diagnosed with type 2 diabetes Hemoglobin (HbA1c) between 7.5% to 9.5% Prescribed an ADA accepted diet Receiving stable dose of metformin alone or in combination with other oral antidiabetic medications for 90 days before Visit 1 History of type 1 diabetes or ketoacidosis History of chronic (more than 2 months) insulin therapy or the initiation of insulin for chronic treatment History of pancreatitis Uncontrolled hypertension Recent severe cardiovascular disease Allergy or toxic response to colesevelam or any of its components Body mass index (BMI) &gt;45 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Diabetes Mellitus</keyword>
</DOC>